What You Should Know:
- The U.S. government’s Joint Pathology Center, which
houses the world’s largest human tissue repository, today announced that
Proscia, a leading digital and AI pathology company, will provide end-to-end
modernization of JPC’s pathology operations.
- The multi-phase project will digitize the world’s
largest human pathology specimen repository in order to enhance biomedical
research for cancer and infectious diseases like COVID-19, and enable easier
data sharing with
Read More
Drug Discovery | Pharma |News, Analysis, Insights - HIT Consultant
4 Areas Driving AI Adoption in Hospital Operations and Patient Safety
COVID-19 has put a tremendous burden on hospitals, and the clinicians, nurses, and medical staff who make them run.
Many hospitals have suffered financially as they did not anticipate the severity of the disease. The extended duration of patient stays in ICUs, the need for more isolated rooms and beds, and the need for better supplies to reduce infections have all added costs. Some hospitals did not have adequate staff to check-in patients, take their temperature, monitor them regularly, or
Read More
Analysis: August Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of August 2020.
M&A is back and the velocity of the rebound has outpaced all expectations. The recovery quickly worked its way across the spectrum from large to small-cap, beginning with the larger cap NASDAQ rally of nearly 80% from lows in late March (only to soften in recent days), followed by multi-billion
Read More
Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics
What You Should Know:
- Repurpose.AI, has partnered with Scripps Research to
discover drug candidates that may be repurposed to treat COVID-19.
- The partnership will leverage Repurpose.AI's ActivPred
AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic
digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is
teaming up with Repurpose.AI, an AI
drug discovery company to develop COVID-19 therapeutics. The
Read More
COVID-19 Outbreak: The Opportunity & Importance of Health Informatics
Never before has health informatics played a greater role in public health than during the COVID-19 pandemic. While the Health IT industry is certainly challenged due to the overall disruption to the healthcare system, the pandemic undoubtedly underscores the opportunity and importance of health informatics, such as telehealth, remote patient monitoring, patient engagement, AI-based drug discovery, precision medicine, and clinical decision support, but nowhere more pressing than the fields of
Read More
Exscientia to Screen 15,000 Drugs in Search for Coronavirus Treatment
What You Should Know:
- Exscientia announced a joint transatlantic initiative with Diamond Light Source, the UK's national synchrotron facility and Calibr, a division of Scripps Research (USA), to screen nearly every known approved and investigational drug against key COVID-19 drug targets to progress compounds that could rapidly become viable drugs for the rapid treatment of the coronavirus.
- Exscientia has gained access to Calibr’s world’s leading collection of 15,000 clinically-ready
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
Chilmark Research: The Promise of AI & ML in Healthcare Report
What You Need to Know:
- New Chilmark Research report reveals artificial intelligence and machine learning (AI/ML) technologies are capturing the imagination of investors and healthcare organizations—and are poised to expand healthcare frontiers.
- The latest report evaluates over 120 commercial AI/ML solutions in healthcare, explores future opportunities, and assesses obstacles to adoption at scale.
Interest and investment in healthcare AI/ML tools
is booming with approximately
Read More
The Many Faces of AI in Clinical Trials
AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs.
The
Read More
Rock Health: 3 Central Themes Driving Digital Health Consumer Adoption
- Rock Health and the Stanford Center for Digital Health release their findings from the 2019 Consumer Adoption Survey. - In 2019, overall consumer adoption of digital health leveled off in 2019 near the 2018 high water mark. - Findings reveal consumer-clinician dialogue and transparency around data collection and sharing will be central to the growth of digital technology in healthcare.Digital health consumer adoption has leveled off in what appears to a slight moderation of digital health
Read More
